CLINICAL_TRIALS
trial_result
· 2024-04-19
Clinical Trial Update: S 48168 (ARM 210) for the Treatment of RYR1-related Myopathies (RYR1-RM) [Phase 1]
Summary
Phase 1 trial of S 48168 (ARM 210) for RYR1-related myopathy has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: RyCarma Therapeutics, Inc. | Conditions: RYR-1 Myopathy | Phase 1 | Status: COMPLETED | Results posted: 2024-04-19